Monday June 26th 2017

Archive for October, 2013

TMS May Reduce Depression, Fatigue in MS Patients TMS May Reduce Depression, Fatigue in MS Patients

TMS May Reduce Depression, Fatigue in MS Patients TMS May Reduce Depression, Fatigue in MS Patients

Deep repetitive transcranial magnetic stimulation of the motor cortex has the potential to reduce fatigue and depression in patients with multiple sclerosis, a new study suggests. Medscape Medical News (Source: Medscape Today Headlines) [Read More]

Walking speed may indicate severity of MS

Walking speed may indicate severity of MS

Doctors may be able to determine the progression and severity of multiple sclerosis in a patient by measuring the time it takes them to walk 25 feet. This is according to a study published in the journal Neurology.MS is a chronic disease of the central nervous system. [Read More]

New Imaging Research Shows Increased Iron In The Brain In Earliest Stages Of MS

New Imaging Research Shows Increased Iron In The Brain In Earliest Stages Of MS

While it’s been known for over a century that iron deposits in the brain play a role in the pathology of Multiple Sclerosis (MS), new imaging research from Western University helps to answer the question of whether these accumulations are a cause or consequence of the [Read More]

 Page 1 of 107  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]